Cancer | pharmaphorum

Wednesday 1 April 2026

Cancer

News

Vaccitech2

Clinical trial begins of lung cancer immunotherapeutic

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine.

Patients

kidney

Putting patient perspectives at the heart of kidney cancer r...

Commissioned by Ipsen.

Oncology

Regulation optimisation could save thousands of life years

Regulation optimisation could save thousands of life years

Embracing a “once-in-a-generation opportunity” to improve access to oncology treatments could save thousands of years of life across the European Union.

Oncology

Using bispecific antibodies to advance cancer immunotherapy

Using bispecific antibodies to advance cancer immunotherapy

Dr Laura Moriarty, senior marketing manager at Bio-Rad, looks at the impressive immuno-therapeutic potential of bispecific antibodies (bsAbs).

Events

pharmaphorum banner

Partner Content

Next Generation CAR-TCR Summit

Engineering Smarter Adoptive Cell Therapies

News

COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality?

England's cancer therapy backlog 'could take more than a dec...

A new report has suggested it could take until 2033 to clear the backlog of cancer treatment in England caused by the pandemic.